- Lonza Group AG Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) from Roche Holding AG Call TranscriptMar 20, 2024
- Full Year 2023 Lonza Group AG Earnings Call TranscriptJan 26, 2024CHF423.9 (+13.98%)Earnings
- Lonza Group AG at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Lonza Group AG Capital Markets Day TranscriptOct 17, 2023
- Half Year 2023 Lonza Group AG Earnings Call TranscriptJul 21, 2023CHF493.9 (-10.75%)Earnings
- Q1 2023 Lonza Group AG Qualitative Update Call TranscriptMay 10, 2023
- Full Year 2022 Lonza Group AG Earnings Call TranscriptJan 25, 2023Earnings
- Lonza Group AG at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Half Year 2022 Lonza Group AG Earnings Call TranscriptJul 22, 2022Earnings
- Full Year 2021 Lonza Group AG Earnings Call TranscriptJan 26, 2022Earnings
- Lonza Group AG Capital Markets Day TranscriptOct 12, 2021
- Half Year 2021 Lonza Group AG Earnings Call TranscriptJul 23, 2021Earnings
- Full Year 2020 Lonza Group AG Earnings Call TranscriptJan 27, 2021Earnings
- Lonza Group AG at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Lonza Group AG Investor Update Call TranscriptOct 15, 2020
- Half Year 2020 Lonza Group AG Earnings Call TranscriptJul 24, 2020Earnings
- Q1 2020 Lonza Group AG Qualitative Update Review Call TranscriptApr 17, 2020
- Full Year 2019 Lonza Group AG Earnings Call TranscriptJan 21, 2020Earnings
- Half Year 2019 Lonza Group AG Earnings Call TranscriptJul 24, 2019Earnings
- Lonza Group AG to Discuss the Carve-out of Lonza Specialty Ingredients Call TranscriptJun 03, 2019
- Q1 2019 Lonza Group AG Business Update Call TranscriptApr 18, 2019
Full Year 2023 Lonza Group AG Earnings Call Transcript
Ladies and gentlemen, welcome to the Full Year Results 2023 Investor and Analyst Conference Call and Live Webcast. I am Sandra, the Chorus Call operator. (Operator Instructions) The conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to Albert Baehny, CEO Interim and Chairman of the Board of Directors. Please go ahead, sir.
Thank you for the introduction. Good morning, and good afternoon to all of you, and thank you for joining our full year results presentation. I will share our performance at the group and divisional level, Philippe Deecke, our CFO, will present the details of our finances. We will also ensure that there is time at the end to take your questions.
Let's start by taking a look at the group results. In 2023, we delivered sales of CHF 6.7 billion, corresponding to a sales growth of 10.9% at a constant exchange rate. A CORE EBITDA of CHF 2 billion delivered
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)